These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 7599336)

  • 1. The effect of nitric oxide donors on the release of plasminogen activator inhibitor (PAI) from rabbit platelets in vitro.
    Korbut R; Marcinkiewicz E; Cieślik K; Gryglewski RJ
    J Physiol Pharmacol; 1995 Mar; 46(1):37-44. PubMed ID: 7599336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The nitric oxide donor SIN-1 is a potent inhibitor of plasminogen activator inhibitor release from stimulated platelets.
    Drummer C; Lüdke S; Spannagl M; Schramm W; Gerzer R
    Thromb Res; 1991 Sep; 63(5):553-6. PubMed ID: 1755008
    [No Abstract]   [Full Text] [Related]  

  • 3. Modulation of angiotensin-converting enzyme by nitric oxide.
    Ackermann A; Fernández-Alfonso MS; Sánchez de Rojas R; Ortega T; Paul M; González C
    Br J Pharmacol; 1998 May; 124(2):291-8. PubMed ID: 9641545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide as a regulator of prostacyclin synthesis in cultured rat heart endothelial cells.
    Sievi E; Lähteenmäki TA; Alanko J; Vuorinen P; Vapaatalo H
    Arzneimittelforschung; 1997 Oct; 47(10):1093-8. PubMed ID: 9368700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of octreotide on epidermal growth factor receptor, tissue plasminogen activator, and plasminogen activator inhibitor during intraperitoneal adhesion formation.
    Lai HS; Chen Y; Chang KJ; Chen WJ
    J Gastroenterol; 2003; 38(6):555-60. PubMed ID: 12825131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effects of mesoionic 3-aryl substituted oxatriazole-5-imine derivatives on vascular smooth muscle cell mitogenesis and proliferation in vitro.
    Lähteenmäki T; Sievi E; Vapaatalo H
    Br J Pharmacol; 1998 Sep; 125(2):402-8. PubMed ID: 9786515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of plasminogen activator inhibitor by products released from platelets.
    Fujii S; Sobel BE
    Circulation; 1990 Oct; 82(4):1485-93. PubMed ID: 2401077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide regulates the calcium current in isolated human atrial myocytes.
    Kirstein M; Rivet-Bastide M; Hatem S; Bénardeau A; Mercadier JJ; Fischmeister R
    J Clin Invest; 1995 Feb; 95(2):794-802. PubMed ID: 7860763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of beta- but not alpha 1-mediated adrenergic responses in isolated hearts and cardiomyocytes by nitric oxide and 8-bromo cyclic GMP.
    Ebihara Y; Karmazyn M
    Cardiovasc Res; 1996 Sep; 32(3):622-9. PubMed ID: 8881523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological quantitation of rabbit plasminogen activator inhibitor-1 in biological samples: evidence that rabbit platelets do not contain PAI-1.
    Ngo TH; Declerck PJ
    Thromb Haemost; 1999 Nov; 82(5):1510-5. PubMed ID: 10595646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombolytic activity of beta-adrenolytic drug, sotalol.
    Korbut R; Swies J; Marcinkiewicz E; Gryglewski RJ
    J Physiol Pharmacol; 1998 Mar; 49(1):51-60. PubMed ID: 9594410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen levels of plasminogen activator inhibitor type 1 in citrated plasma: determination of the contribution of platelets.
    Grimaudo V; Bachmann F; Kruithof EK
    Haemostasis; 1990; 20(6):329-33. PubMed ID: 2151572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide.
    Jurasz P; Sawicki G; Duszyk M; Sawicka J; Miranda C; Mayers I; Radomski MW
    Cancer Res; 2001 Jan; 61(1):376-82. PubMed ID: 11196190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased intraocular pressure induced by nitric oxide donors is correlated to nitrite production in the rabbit eye.
    Behar-Cohen FF; Goureau O; D'Hermies F; Courtois Y
    Invest Ophthalmol Vis Sci; 1996 Jul; 37(8):1711-5. PubMed ID: 8675417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The roles of alpha 2-antiplasmin and plasminogen activator inhibitor 1 (PAI-1) in the inhibition of clot lysis.
    Robbie LA; Booth NA; Croll AM; Bennett B
    Thromb Haemost; 1993 Aug; 70(2):301-6. PubMed ID: 8236139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetylsalicylic acid inhibits platelet PAI-1 antigen release without affecting circulating PAI-1 antigen in plasma.
    Cogo A; Ling E; Sturk A; ten Cate JW; Prandoni P
    Ric Clin Lab; 1990; 20(2):113-7. PubMed ID: 2371491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide donors as generators and scavengers of superoxide anions.
    Robak J; Gryglewski RJ
    Pol J Pharmacol; 1993; 45(1):51-8. PubMed ID: 8401759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study on the action of vitamin E supplementation on plasminogen activator inhibitor type 1 and platelet nitric oxide production in type 2 diabetic patients.
    Vignini A; Nanetti L; Moroni C; Testa R; Sirolla C; Marra M; Manfrini S; Fumelli D; Marcheselli F; Mazzanti L; Rabini RA
    Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):15-22. PubMed ID: 17949955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxygen modulation of guanylate cyclase-mediated retinal pericyte relaxations with 3-morpholino-sydnonimine and atrial natriuretic peptide.
    Haefliger IO; Anderson DR
    Invest Ophthalmol Vis Sci; 1997 Jul; 38(8):1563-8. PubMed ID: 9224284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nitric oxide and cardiologic drugs].
    Kopff M; Kowalczyk E; Kopff A
    Pol Merkur Lekarski; 2005 May; 18(107):521-3. PubMed ID: 16161946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.